InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,447.87
(
-0.31%
)
US TECH 100
19,053.60
(
0.50%
)
Dow Jones
39,411.21
(
0.67%
)
Brent Oil
84.71
(
-0.66%
)
Bitcoin
61,278.23
(
1.69%
)
Post# of 252337
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

ghmm

Send PM Follow Ignore
Followers 50
Posts 6343
Boards Moderated 0
Alias Born 01/22/2006

ghmm

Re: biomaven0 post# 181568

Sunday, 08/31/2014 8:56:11 PM

Sunday, August 31, 2014 8:56:11 PM

Post# of 252337
Maybe not the best example... InterMune's ASCEND trial was tweaked slightly based on one successful and one failed Phase 3. I give the company a lot of credit too, I was a bit skeptical the "tweak" would do much and was a bit worried it may back fire but it would appear that ASCEND results are superior to even the successful CAPACITY-2.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up